Renal impact of Impella CP® use in the DanGer Shock substudy
The DanGer Shock clinical trial substudy analyzes the relationship between the use of the microaxial flow pump (Impella CP®) and renal dysfunction in patients with cardiogenic shock secondary to myocardial infarction.